Biopharmx (BPMX) Stock Price, News & Analysis

Company Overview

BioPharmX Corporation was a specialty pharmaceutical company focused on developing and commercializing treatments for dermatological conditions. Its work centered on topical therapies intended to address unmet needs in acne and other skin disorders.

The company’s primary product candidate was BPX-01, a topical minocycline gel developed for the treatment of moderate-to-severe acne vulgaris. BioPharmX also pursued delivery technologies designed to improve the topical administration of pharmaceutical ingredients while potentially reducing some limitations associated with oral therapies.

BioPharmX was based in the United States and operated primarily in the dermatology pharmaceutical market. The company later underwent corporate changes, and its operations and assets were associated with Journey Medical Corporation. Because BioPharmX is no longer an active standalone public company under its former identity, current information about its leadership, products and commercial operations is limited.

Key Stats

• Today's Range: N/A
• 50-Day Range: N/A
• 52-Week Range: N/A
• Volume: 336,508 shs
• Average Volume: 2.15 million shs
• Market Capitalization: $111.86 million
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

Company Calendar

• Last Earnings: 12/10/2019
• Today: 9/26/2026

Industry, Sector and Symbol

• Stock Exchange: NYSEAMERICAN
• Sector: Healthcare
• Industry: Biotechnology
• Sub-Industry: Biotechnology
• Current Symbol: NYSEAMERICAN:BPMX
• Previous Symbol: NYSE:BPMX
• CIK: N/A
• Web: www.biopharmx.com
• Phone: +1-650-8895020
• Fax: N/A
• Employees: 17
• Year Founded: N/A

Profitability

• EPS (Trailing Twelve Months): N/A
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: N/A
• Net Margins: N/A
• Pretax Margin: N/A
• Return on Equity: N/A
• Return on Assets: N/A

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: N/A
• Quick Ratio: N/A

Sales & Book Value

• Annual Sales: N/A
• Price / Sales: N/A
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: N/A
• Price / Book: N/A

Miscellaneous

• Outstanding Shares: 18,278,000
• Free Float: N/A
• Market Cap: $111.86 million
• Optionable: Not Optionable
• Beta: N/A